Oppenheimer Initiates AFFX At Perform

Oppenheimer initiating coverage of Affymetrix Inc. AFFX with a Perform rating.

“Affymetrix is a life science tools company primarily known for its microarray franchise,” Oppenheimer writes. “Recently, the company has begun a diversification strategy to reduce its reliance on traditional academic and government sources.”

Affymetrix closed today at $4.47.